Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2057-3804
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prediction of doxorubicin cardiotoxicity by early detection of subclinical right ventricular dysfunction ; volume:6 ; number:1 ; day:23 ; month:7 ; year:2020 ; pages:1-8 ; date:12.2020
Cardio-Oncology ; 6, Heft 1 (23.7.2020), 1-8, 12.2020
- Urheber
-
Planek, Maria Isabel Camara
Manshad, Ahmad
Hein, Kyaw
Hemu, Mohamad
Ballout, Fatima
Varandani, Rajiv
Venugopal, Parameswaran
Okwuosa, Tochukwu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40959-020-00066-8
- URN
-
urn:nbn:de:101:1-2020091620232571991066
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Planek, Maria Isabel Camara
- Manshad, Ahmad
- Hein, Kyaw
- Hemu, Mohamad
- Ballout, Fatima
- Varandani, Rajiv
- Venugopal, Parameswaran
- Okwuosa, Tochukwu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction
Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin
Vaccarin Ameliorates Doxorubicin-Induced Cardiotoxicity via Inhibition of p38 MAPK Mediated Mitochondrial Dysfunction
eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction
Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Doxorubicin cardiotoxicity and target cells: a broader perspective
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Glucose-regulated protein 78 (GRP78) overexpression inhibits doxorubicin cardiotoxicity
Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus
Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction
Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin
Vaccarin Ameliorates Doxorubicin-Induced Cardiotoxicity via Inhibition of p38 MAPK Mediated Mitochondrial Dysfunction
eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction
Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Doxorubicin cardiotoxicity and target cells: a broader perspective
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Glucose-regulated protein 78 (GRP78) overexpression inhibits doxorubicin cardiotoxicity
Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus
Subclinical HMOD in Hypertension: Left Ventricular Diastolic Dysfunction
Detection of subclinical cardiotoxicity in sarcoma patients receiving continuous doxorubicin infusion or pre-treatment with dexrazoxane before bolus doxorubicin
Vaccarin Ameliorates Doxorubicin-Induced Cardiotoxicity via Inhibition of p38 MAPK Mediated Mitochondrial Dysfunction
eEF2K alleviates doxorubicin-induced cardiotoxicity by inhibiting GSK3β and improving autophagy dysfunction
Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in mice
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
Doxorubicin cardiotoxicity and target cells: a broader perspective
Circular RNA insulin receptor protects against doxorubicin-mediated cardiotoxicity
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Glucose-regulated protein 78 (GRP78) overexpression inhibits doxorubicin cardiotoxicity